[HTML][HTML] Management of high-risk pulmonary embolism in pregnancy

M Blondon, BM de Tejada, F Glauser, M Righini… - Thrombosis research, 2021 - Elsevier
Pregnancy-associated high-risk pulmonary embolism (PE) is among the most frequent
causes of maternal mortality in the Western world, by causing hemodynamic instability and …

Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis

W Rozi, A Rahhal, EA Ali, A Al-Mashdali… - Blood …, 2022 - ashpublications.org
Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis | Blood
Advances | American Society of Hematology Skip to Main Content Advertisement Umbrella Alt …

How I treat dysfibrinogenemia

A Casini, P de Moerloose - Blood, The Journal of the American …, 2021 - ashpublications.org
Congenital dysfibrinogenemia (CD) is caused by structural changes in fibrinogen that modify
its function. Diagnosis is based on discrepancy between decreased fibrinogen activity and …

Complicaciones hemorrágicas y trombóticas del embarazo: diagnóstico, prevención y tratamiento

CS Alvarado, A Celis-López, E Guevara-Ríos… - Anales de la Facultad …, 2023 - scielo.org.pe
Las hemorragias y la enfermedad tromboembólica venosa (ETEV) figuran entre las cinco
causas más frecuentes de morbilidad y mortalidad materna en el mundo. Revisamos la …

[HTML][HTML] Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study

IM Bistervels, HMG Wiegers, FN Áinle… - Journal of Thrombosis …, 2023 - Elsevier
Background Peripartum management of women using low-molecular-weight heparin
(LMWH) varies widely. Minimum time intervals are required between LMWH injection and …

Pulmonary embolism during pregnancy: an updated review with case series description

G Cueto-Robledo, FD Cervantes-Naranjo… - Current Problems in …, 2023 - Elsevier
Pulmonary embolism (PE) is a potentially life-threatening condition that can occur during
pregnancy and pose a significant risk to the mother and the developing fetus. It is a major …

[HTML][HTML] Bleeding in women with venous thromboembolism during pregnancy: a systematic review of the literature

C Simard, L Gerstein, T Cafaro, KB Filion… - Research and Practice …, 2022 - Elsevier
Objectives Venous thromboembolism (VTE) represents an important cause of maternal
morbidity and mortality. Estimates of bleeding associated with therapeutic‐dose …

Cerebral venous sinus thrombosis in pregnancy and puerperium: A comprehensive review

H Algahtani, A Bazaid, B Shirah, RN Bouges - Brain Circulation, 2022 - journals.lww.com
Cerebral venous sinus thrombosis (CVST) is a distinct neurological emergency caused by
occlusion, either partial or complete, of the dural venous sinus and/or the cerebral veins. It …

Pregnancy outcomes in women with Budd–Chiari syndrome or portal vein thrombosis–a multicentre retrospective cohort study

HMG Wiegers, EN Hamulyák… - … Journal of Obstetrics …, 2022 - Wiley Online Library
Objective To evaluate current practice and outcomes of pregnancy in women previously
diagnosed with Budd–Chiari syndrome and/or portal vein thrombosis, with and without …

Fondaparinux pre-, peri-, and/or postpartum for the prophylaxis/treatment of venous thromboembolism (FondaPPP)

CE Dempfle, J Koscielny… - Clinical and Applied …, 2021 - journals.sagepub.com
We analyzed data for women who received fondaparinux for≥ 7 days during pregnancy.
The study retrospectively included women who received fondaparinux pre-, peri-and/or …